- Home
- AORT vs SPRY Comparison
AORT vs SPRY Comparison
Compare AORT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- SPRY
- Stock Information
- Founded
- AORT 1984
- SPRY 2015
- Country
- AORT United States
- SPRY United States
- Employees
- AORT N/A
- SPRY N/A
- Industry
- AORT Medical/Dental Instruments
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- AORT Health Care
- SPRY Health Care
- Exchange
- AORT Nasdaq
- SPRY Nasdaq
- Market Cap
- AORT 1.2B
- SPRY 1.1B
- IPO Year
- AORT 1993
- SPRY N/A
- Fundamental
- Price
- AORT $30.73
- SPRY $12.57
- Analyst Decision
- AORT Strong Buy
- SPRY Strong Buy
- Analyst Count
- AORT 5
- SPRY 4
- Target Price
- AORT $31.80
- SPRY $26.00
- AVG Volume (30 Days)
- AORT 343.4K
- SPRY 1.5M
- Earning Date
- AORT 02-13-2025
- SPRY 11-13-2024
- Dividend Yield
- AORT N/A
- SPRY N/A
- EPS Growth
- AORT N/A
- SPRY N/A
- EPS
- AORT N/A
- SPRY N/A
- Revenue
- AORT $384,899,000.00
- SPRY $2,568,000.00
- Revenue This Year
- AORT $12.95
- SPRY $66,750.00
- Revenue Next Year
- AORT $9.76
- SPRY $508.63
- P/E Ratio
- AORT N/A
- SPRY N/A
- Revenue Growth
- AORT 13.29
- SPRY 8460.00
- 52 Week Low
- AORT $16.48
- SPRY $6.00
- 52 Week High
- AORT $32.33
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- AORT 61.77
- SPRY 58.86
- Support Level
- AORT $28.83
- SPRY $11.00
- Resistance Level
- AORT $32.33
- SPRY $12.48
- Average True Range (ATR)
- AORT 0.97
- SPRY 0.81
- MACD
- AORT 0.21
- SPRY 0.28
- Stochastic Oscillator
- AORT 66.84
- SPRY 84.95
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.